Clinical Trial to Evaluate the Effect and Safety of MSV in Xerostomy

Exclusion Criteria

• •1. Participation in another clinical trial in the 3 months prior to his/her inclusion.
• •2. Present infection (no infectious sign should be evidenced with repercussion on the evolution of the treated lesion).
• •3. Patients with positive serologies for HIV, lues and hepatitis with positive viral load.
• •4. History of cancer in the last 2 years. History of teratoma, adenocarcinoma derived from one of the salivary glands, lymphoma of the tonsils or some other lymphatic tissue or melanoma of pigmented cells of the oral mucosa.
• •5. Xerogenic medication in progress.
• •6. Other diseases of the salivary glands, for example, Sjögren's syndrome, sialolithiasis, etc.
• •7. Local infection.
• •8. Pregnancy or pregnancy planned within the next 2 years.
• •9. Breastfeeding.
• •10. Treatment with anticoagulants (not interruptible in MO or application).
• •11. Any other illness or condition that is grounds for exclusion for the investigator.